Medicare Enrolled
Dr. Lucio Gordan, MD
Hematology · Gainesville, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gordan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gordan? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gordan
Dr. Lucio Gordan is a hematology in Gainesville, FL, with 20 years in practice. Based on federal Medicare data, Dr. Gordan performed 89,308 Medicare services across 3,313 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gordan received a total of $42,442 from 65 pharmaceutical and/or device companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gordan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 48% volume in FL$ $42,442 industry payments
Medicare Practice Summary
Medicare Utilization ↗89,308
Medicare services
Top 48% in FL for hematology
3,313
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,465 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 36,210 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 9,750 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 9,180 | $19 | $51 |
| Paclitaxel chemotherapy injection | 8,761 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 6,200 | $6 | $23 |
| Iron infusion (Monoferric) | 4,700 | $16 | $57 |
| Dexamethasone injection (steroid) | 2,840 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,276 | $8 | $29 |
| Blood draw (venipuncture) | 2,106 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,230 | $1 | $28 |
| Office visit, established patient (30-39 min) | 1,180 | $93 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 564 | $0 | $9 |
| Drug injection, under skin or into muscle | 503 | $10 | $69 |
| Administration of chemotherapy into vein, 1 hour or less | 373 | $96 | $378 |
| Injection of additional new drug or substance into vein | 348 | $12 | $61 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 343 | $21 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 315 | $47 | $189 |
| Injection, zoledronic acid, 1 mg | 278 | $6 | $69 |
| Injection, diphenhydramine hcl, up to 50 mg | 194 | $1 | $3 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 184 | $15 | $59 |
| Administration of chemotherapy into vein, each additional hour | 165 | $21 | $79 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 147 | $55 | $206 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 135 | $1 | $6 |
| Infusion into a vein for hydration, each additional hour | 131 | $10 | $42 |
| Office visit, established patient (20-29 min) | 130 | $58 | $239 |
| Red blood count, automated test | 126 | $4 | $10 |
| Administration of additional new drug or substance into vein, 1 hour or less | 121 | $47 | $178 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 104 | $25 | $89 |
| Office visit, established patient, complex (40-54 min) | 103 | $130 | $474 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 91 | $114 | $562 |
| New patient office visit (45-59 min) | 66 | $121 | $453 |
| Automated urinalysis | 65 | $2 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 61 | $15 | $56 |
| Infusion, normal saline solution , 1000 cc | 60 | $2 | $7 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 49 | $1 | $7 |
| Injection of drug or substance into vein | 44 | $27 | $156 |
| Infusion into a vein for hydration, 31-60 minutes | 40 | $23 | $156 |
| Administration of additional new drug or substance into vein using push technique | 36 | $40 | $170 |
| Drawing of blood for a medical problem | 33 | $66 | $277 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 32 | $4 | $15 |
| New patient office visit, complex (60-74 min) | 21 | $151 | $585 |
| Transitional care management services for problem of at least moderate complexity | 13 | $158 | $533 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
46.9% high complexity
45.7% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$42,442
Total received (2018-2024)
Avg $6,063/year across 7 years
Top 11% in FL for hematology
65
Companies
192
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,358 (55.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,601 (22.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,483 (22.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,937
2023$7,767
2022$9,222
2021$1,925
2020$4,181
2019$8,090
2018$5,321
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$9,530
Illumina, Inc.
$5,876
Celgene Corporation
$4,549
E.R. Squibb & Sons, L.L.C.
$3,882
Jazz Pharmaceuticals Inc.
$2,250
SANOFI-AVENTIS U.S. LLC
$1,871
AbbVie, Inc.
$1,650
GENZYME CORPORATION
$1,619
Novartis Pharmaceuticals Corporation
$1,476
Seattle Genetics, Inc.
$1,402
MorphoSys, US Inc.
$1,338
AVEO Pharmaceuticals, Inc.
$900
PFIZER INC.
$728
Janssen Global Services, LLC
$585
Ipsen Biopharmaceuticals, Inc
$519
Amgen Inc.
$430
Genentech USA, Inc.
$329
Daiichi Sankyo Inc.
$328
Astellas Pharma US Inc
$268
McKesson Drug Company LLC
$233
Foundation Medicine, Inc.
$225
Spectrum Pharmaceuticals Inc.
$189
BeiGene USA, Inc.
$176
Bayer Healthcare Pharmaceuticals Inc.
$169
ASD Specialty Healthcare, LLC
$146
Lilly USA, LLC
$141
Clovis Oncology, Inc.
$130
ASD SPECIALTY HEALTHCARE, LLC
$126
Pharmacyclics LLC, An AbbVie Company
$112
Bayer HealthCare Pharmaceuticals Inc.
$108
AmerisourceBergen Drug Corporation
$93
AMAG Pharmaceuticals, Inc.
$90
Adaptive Biotechnologies Corporation
$82
Boehringer Ingelheim Pharmaceuticals, Inc.
$82
Merck Sharp & Dohme Corporation
$79
Mirati Therapeutics, Inc.
$72
Karyopharm Therapeutics Inc.
$55
TESARO, Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$43
NanoString Technologies, Inc.
$36
MEDIVATION FIELD SOLUTIONS LLC
$31
CTI BioPharma Corp.
$28
TerSera Therapeutics LLC
$27
JAZZ PHARMACEUTICALS INC.
$26
Gilead Sciences, Inc.
$25
EMD Serono, Inc.
$25
EISAI INC.
$24
Exelixis Inc.
$23
Octapharma USA, Inc.
$21
AbbVie Inc.
$21
Myriad Genetic Laboratories, Inc.
$18
Aurobindo Pharma USA, Inc.
$18
Taiho Oncology, Inc.
$18
Seagen Inc.
$17
GlaxoSmithKline, LLC.
$16
Agios Pharmaceuticals, Inc.
$16
PharmaEssentia USA Corporation
$16
Eisai Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Merck Sharp & Dohme LLC
$15
Sun Pharmaceutical Industries Inc.
$14
GE HealthCare
$14
Kite Pharma, Inc.
$13
SERVIER PHARMACEUTICALS LLC
$13
Veracyte, Inc.
$6
Top 3 companies account for 47.0% of total payments
Associated products mentioned in payments ›
ADCETRIS · Abraxane · Alecensa · BESREMI · BOSULIF · BRUKINSA · Bavencio · Cabometyx · DARZALEX · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · Erleada · FEMARA · FERAHEME · FOTIVDA · FOUNDATIONONE · GAMMAGARD · GAZYVA · GILOTRIF · Herceptin · IDHIFA · IMBRUVICA · INLYTA · Imbruvica · JEVTANA · Jivi · KEYTRUDA · KISQALI · KRAZATI · KYMRIAH · Kyprolis · LONSURF · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · Neulasta · NovaSeq 6000Dx Sequencer Instrument · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDIVO · Oncology Testing · Onivyde · PROMACTA · PROSIGNA ASSAY · Padcev · Pomalyst · Prolia · REBLOZYL · ROLVEDON · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · TECVAYLI · TIBSOVO · TUKYSA · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XPOVIO · XTANDI · Xofigo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (55%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $48 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
8
Per 100K population
2.8
County median income
$59,659
Nearest hospital
HCA FLORIDA NORTH FLORIDA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gordan is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 11%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gordan experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Gordan performed 36,210 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gordan receive payments from pharmaceutical companies?
Yes. Dr. Gordan received a total of $42,442 from 65 companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gordan's costs compare to other hematologys in Gainesville?
Dr. Gordan's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gordan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Gainesville
Browse hematologys in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Illumina, Inc. Payments to Doctors
See all physicians who received payments from Illumina, Inc..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology